Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis

Abstract

These findings demonstrate that ATRA treatment ameliorates severity of EAU and reduces the Th1/Th17 responses. ATRA may represent a new therapeutic modality for human refractory uveitis.